Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Medical Officer

President & CFO

Chief Executive Officer

Chief Financial Officer

Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for patients suffering from congenital adrenal hyperplasia (CAH), which is in Phase 2b clinical trial; and to evaluate glucocorticoid reduction in adult patients with classic CAH that is Phase 2b clinical trial. It is also developing tildacerfont for the treatment of pediatric classic congenital adrenal hyperplasia in children that is in Phase 2 clinical trial; and for females with polycystic ovary syndrome, which is in Phase 2 clinical trial. The company has a license agreement with Eli Lilly and Company to research, develop, and commercialize compounds for various pharmaceutical uses; and collaboration and license agreement with Kaken Pharmaceutical Co. Ltd. to develop, manufacture, and commercialize tildacerfont for the treatment of CAH in Japan. Spruce Biosciences, Inc. was incorporated in 2014 and is headquartered in South San Francisco, California.

Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disord...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-03-21	Premium	sold	Premium	Premium	Premium	-
2024-03-20	Premium	sold	Premium	Premium	Premium	-
2024-03-19	Premium	sold	Premium	Premium	Premium	-
2024-03-18	Premium	sold	Premium	Premium	Premium	-
2024-03-14	Premium	sold	Premium	Premium	Premium	-
2023-12-29	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2023-12-29	Premium	acquired	Premium	Premium	Premium	President & CFO
2023-12-15	Premium	sold (taxes)	Premium	Premium	Premium	President & CFO
2023-12-15	Premium	acquired	Premium	Premium	Premium	President & CFO
2023-12-15	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2023-12-15	Premium	sold (taxes)	Premium	Premium	Premium	Chief Executive Officer
2023-12-15	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2023-12-15	Premium	sold (taxes)	Premium	Premium	Premium	Chief Medical Officer
2023-06-30	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2023-06-30	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2023-06-30	Premium	acquired	Premium	Premium	Premium	President & CFO
2023-06-30	Premium	acquired	Premium	Premium	Premium	President & CFO
2023-06-30	Premium	sold (taxes)	Premium	Premium	Premium	President & CFO
2023-02-16	Premium	bought	Premium	Premium	Premium	-
2023-02-16	Premium	bought	Premium	Premium	Premium	-
2023-01-03	Premium	sold (taxes)	Premium	Premium	Premium	President & CFO
2023-01-03	Premium	acquired	Premium	Premium	Premium	President & CFO
2022-12-30	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2022-12-30	Premium	acquired	Premium	Premium	Premium	Chief Executive Officer
2022-12-30	Premium	acquired	Premium	Premium	Premium	President & CFO

SPRB - Spruce Biosciences Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for SPRB